Improving Outcomes for Esophageal Cancer using Proton Beam Therapy

Michael D. Chuong, Christopher L. Hallemeier, Salma Jabbour, Jen Yu, Shahed Badiyan, Kenneth W. Merrell, Mark V. Mishra, Heng Li, Vivek Verma, Steven H. Lin

Research output: Contribution to journalReview article

35 Citations (Scopus)

Abstract

Radiation therapy (RT) plays an essential role in the management of esophageal cancer. Because the esophagus is a centrally located thoracic structure there is a need to balance the delivery of appropriately high dose to the target while minimizing dose to nearby critical structures. Radiation dose received by these critical structures, especially the heart and lungs, may lead to clinically significant toxicities, including pneumonitis, pericarditis, and myocardial infarction. Although technological advancements in photon RT delivery like intensity modulated RT have decreased the risk of such toxicities, a growing body of evidence indicates that further risk reductions are achieved with proton beam therapy (PBT). Herein we review the published dosimetric and clinical PBT literature for esophageal cancer, including motion management considerations, the potential for reirradiation, radiation dose escalation, and ongoing esophageal PBT clinical trials. We also consider the potential cost-effectiveness of PBT relative to photon RT.

Original languageEnglish (US)
Pages (from-to)488-497
Number of pages10
JournalInternational Journal of Radiation Oncology Biology Physics
Volume95
Issue number1
DOIs
StatePublished - May 1 2016

Fingerprint

Proton Therapy
Esophageal Neoplasms
proton beams
radiation therapy
therapy
Radiotherapy
cancer
infarction
dosage
Photons
toxicity
delivery
Radiation
myocardial infarction
esophagus
cost effectiveness
Pericarditis
photons
radiation
Risk Reduction Behavior

All Science Journal Classification (ASJC) codes

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Chuong, Michael D. ; Hallemeier, Christopher L. ; Jabbour, Salma ; Yu, Jen ; Badiyan, Shahed ; Merrell, Kenneth W. ; Mishra, Mark V. ; Li, Heng ; Verma, Vivek ; Lin, Steven H. / Improving Outcomes for Esophageal Cancer using Proton Beam Therapy. In: International Journal of Radiation Oncology Biology Physics. 2016 ; Vol. 95, No. 1. pp. 488-497.
@article{35f34a8cee444e80926bc1830cdd5f4b,
title = "Improving Outcomes for Esophageal Cancer using Proton Beam Therapy",
abstract = "Radiation therapy (RT) plays an essential role in the management of esophageal cancer. Because the esophagus is a centrally located thoracic structure there is a need to balance the delivery of appropriately high dose to the target while minimizing dose to nearby critical structures. Radiation dose received by these critical structures, especially the heart and lungs, may lead to clinically significant toxicities, including pneumonitis, pericarditis, and myocardial infarction. Although technological advancements in photon RT delivery like intensity modulated RT have decreased the risk of such toxicities, a growing body of evidence indicates that further risk reductions are achieved with proton beam therapy (PBT). Herein we review the published dosimetric and clinical PBT literature for esophageal cancer, including motion management considerations, the potential for reirradiation, radiation dose escalation, and ongoing esophageal PBT clinical trials. We also consider the potential cost-effectiveness of PBT relative to photon RT.",
author = "Chuong, {Michael D.} and Hallemeier, {Christopher L.} and Salma Jabbour and Jen Yu and Shahed Badiyan and Merrell, {Kenneth W.} and Mishra, {Mark V.} and Heng Li and Vivek Verma and Lin, {Steven H.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.ijrobp.2015.11.043",
language = "English (US)",
volume = "95",
pages = "488--497",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "1",

}

Chuong, MD, Hallemeier, CL, Jabbour, S, Yu, J, Badiyan, S, Merrell, KW, Mishra, MV, Li, H, Verma, V & Lin, SH 2016, 'Improving Outcomes for Esophageal Cancer using Proton Beam Therapy', International Journal of Radiation Oncology Biology Physics, vol. 95, no. 1, pp. 488-497. https://doi.org/10.1016/j.ijrobp.2015.11.043

Improving Outcomes for Esophageal Cancer using Proton Beam Therapy. / Chuong, Michael D.; Hallemeier, Christopher L.; Jabbour, Salma; Yu, Jen; Badiyan, Shahed; Merrell, Kenneth W.; Mishra, Mark V.; Li, Heng; Verma, Vivek; Lin, Steven H.

In: International Journal of Radiation Oncology Biology Physics, Vol. 95, No. 1, 01.05.2016, p. 488-497.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Improving Outcomes for Esophageal Cancer using Proton Beam Therapy

AU - Chuong, Michael D.

AU - Hallemeier, Christopher L.

AU - Jabbour, Salma

AU - Yu, Jen

AU - Badiyan, Shahed

AU - Merrell, Kenneth W.

AU - Mishra, Mark V.

AU - Li, Heng

AU - Verma, Vivek

AU - Lin, Steven H.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Radiation therapy (RT) plays an essential role in the management of esophageal cancer. Because the esophagus is a centrally located thoracic structure there is a need to balance the delivery of appropriately high dose to the target while minimizing dose to nearby critical structures. Radiation dose received by these critical structures, especially the heart and lungs, may lead to clinically significant toxicities, including pneumonitis, pericarditis, and myocardial infarction. Although technological advancements in photon RT delivery like intensity modulated RT have decreased the risk of such toxicities, a growing body of evidence indicates that further risk reductions are achieved with proton beam therapy (PBT). Herein we review the published dosimetric and clinical PBT literature for esophageal cancer, including motion management considerations, the potential for reirradiation, radiation dose escalation, and ongoing esophageal PBT clinical trials. We also consider the potential cost-effectiveness of PBT relative to photon RT.

AB - Radiation therapy (RT) plays an essential role in the management of esophageal cancer. Because the esophagus is a centrally located thoracic structure there is a need to balance the delivery of appropriately high dose to the target while minimizing dose to nearby critical structures. Radiation dose received by these critical structures, especially the heart and lungs, may lead to clinically significant toxicities, including pneumonitis, pericarditis, and myocardial infarction. Although technological advancements in photon RT delivery like intensity modulated RT have decreased the risk of such toxicities, a growing body of evidence indicates that further risk reductions are achieved with proton beam therapy (PBT). Herein we review the published dosimetric and clinical PBT literature for esophageal cancer, including motion management considerations, the potential for reirradiation, radiation dose escalation, and ongoing esophageal PBT clinical trials. We also consider the potential cost-effectiveness of PBT relative to photon RT.

UR - http://www.scopus.com/inward/record.url?scp=84963533301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963533301&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2015.11.043

DO - 10.1016/j.ijrobp.2015.11.043

M3 - Review article

VL - 95

SP - 488

EP - 497

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 1

ER -